tirzepatide dual agonist is a first-in-class targeting both GIP and GLP-1 receptors, offering a powerful and synergistic approach to glycaemic control and weight management. By acting on multiple metabolic pathways, tirzepatide: Enhances The Tirzepatide Revolution: Is Dual

To view or add a comment, sign in Beyond Weight Loss: The New Era of Obesity Medicine with Triple-Agonists and Complication-Centric Care The landscape of obesity medicine is transforming at an unprecedented pace

Men can be diagnosed with hypogonadism at any age, but it is more prevalent in older males

Interestingly, many additional benefits of taking the medication have been reported, including: Reduced cravings and thoughts around food The ability to view food as fuel rather than comfort Increased adherence to exercise plans Increased intake of vegetables Improved cardiovascular health Ozempic and Wegovy are given as a once-weekly self-injection

291 , L46L57 (2006)